
Newly detected DNA changes may eventually lead to better treatments By Jenifer Goodwin Wednesday, Feb. 9 (HealthDay News) -- Genetic sequencing of the entire prostate cancer cell genome revealed never-before-seen changes in DNA that may contribute to tumor growth, new research finds. By mapping the full genetic blueprint of the tumor, researchers hope the information will eventually lead to the development of more targeted drugs and a better understanding of which prostate cancers are likely to spread, one of the biggest challenges for physicians and patients. "With additional studies and as we sequence more prostate cancer genomes, we may be able to distinguish benign from more aggressive prostate cancers and prevent unnecessary surgeries and treatments," said lead study author Michael Berger, now an assistant professor of pathology at Memorial Sloan-Kettering Cancer Center in New York City. CLICK TO READ MORE |


| Especially for Prostate Cancer Survivors & Those Newly Diagnosed... |
| Receive notice to your cellphone or email when vipfriendsonline.com is updated! |
PROSTATE HEALTH NEWS constantly updated PLEASE BE PATIENT WHILE CONTENT LOADS Click LInk to Article |
| CLICK IMAGE BELOW TO EXPAND IN NEW WINDOW |
| NEWS! |

